This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 May-Jun;136(3):82-4.

doi: 10.1136/ebm.7.3.82.

Losartan was renoprotective in diabetic nephropathy independent of its effect on blood pressure

Christian G Rabbat¹

Affiliations

PMID: 11985425
DOI: 10.1136/ebm.7.3.82

Comment

Losartan was renoprotective in diabetic nephropathy independent of its effect on blood pressure

Christian G Rabbat. ACP J Club. 2002 May-Jun.

. 2002 May-Jun;136(3):82-4.

doi: 10.1136/ebm.7.3.82.

Author

Christian G Rabbat¹

Affiliation

¹ McMaster University, Hamilton, Ontario, Canada.

PMID: 11985425
DOI: 10.1136/ebm.7.3.82

No abstract available

PubMed Disclaimer

Comment on

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.
Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S; RENAAL Study Investigators. Brenner BM, et al. N Engl J Med. 2001 Sep 20;345(12):861-9. doi: 10.1056/NEJMoa011161. N Engl J Med. 2001. PMID: 11565518 Clinical Trial.

Publication types

Actions